Companies: 10,795·Total market cap: $144.5T
Haemonetics Corporation

Haemonetics Corporation

HAENYSEHealthcare● Active
$72.22
+$0.94(+1.32%)
Market Cap$3.3B
P/E Ratio
52W High$87.32
52W Low$47.32

Haemonetics Corporation (HAE) Insider Trading

Form 4 buy vs sell counts, ratio, and sentiment — switch this quarter or last 12 months; chart and transactions below.

SEC EDGAR · FMP · HAE · as of Jun 8, 2026

Activity summary

Buy transactions

1

P-Purchase only

Sell transactions

0

12 Months

Buy/Sell ratio

Buy/Sell (by trades)

Overall sentiment

BULLISH
↑ Buy 100%Active transactions only · RSU vesting excluded0% Sell ↓

Haemonetics Corporation insiders have been net buyers of shares over the past 12 Months, which may signal confidence in the company's outlook.

Source: SEC EDGAR · Form 3 & 4 · via Financial Modeling Prep · Buy = P-Purchase only · Sell = S-Sale only

As of Jun 8, 2026

HAE insider buying and selling by quarter

HAE insider selling · HAE insider buying stocks · quarterly insider activity

Total insider buying (incl. awards)Total insider selling
403K201K0
2024 Q4
2025 Q2
2025 Q3
2025 Q4

Mobile shows last 4Q · Desktop shows full 8Q

Source: SEC EDGAR · Form 3 & 4 · via Financial Modeling Prep · last 8 quarters

As of Jun 8, 2026

Active insiders

Most active in past 12 months · HAE ceo insider trading

Showing all insiders · Click a card to filter the transactions table below

Aggregated from reportingName · top 5 by trade count (12M) · no extra API

Recent insider transactions

HAE executive sell shares · HAE board member insider trading · HAE insider trading SEC filing

Showing 87 most recent · Common Stock · Form 4 only

Scroll horizontally to see all columns

Basil Michelle L

EVP and General Counsel

Award

Date

May 15

Shares

28,424

Price

Value

View Form 4 on SEC.gov

Basil Michelle L

EVP and General Counsel

Other

Date

May 15

Shares

2,913

Price

$56.29

Value

$164K

View Form 4 on SEC.gov

Chan Frank

EVP, Chief Operating Officer

Award

Date

May 15

Shares

27,535

Price

Value

View Form 4 on SEC.gov

Chan Frank

EVP, Chief Operating Officer

Other

Date

May 15

Shares

546

Price

$56.29

Value

$31K

View Form 4 on SEC.gov

DArecca James

EVP, Chief Financial Officer

Award

Date

May 15

Shares

29,312

Price

Value

View Form 4 on SEC.gov

DArecca James

EVP, Chief Financial Officer

Other

Date

May 15

Shares

2,505

Price

$56.29

Value

$141K

View Form 4 on SEC.gov

Maunsell Farris Maryanne

VP, Chief Accounting Officer

Award

Date

May 15

Shares

2,220

Price

Value

View Form 4 on SEC.gov

Maunsell Farris Maryanne

VP, Chief Accounting Officer

Other

Date

May 15

Shares

197

Price

$56.29

Value

$11K

View Form 4 on SEC.gov

Galvin Roy

EVP, Chief Commercial Officer

Award

Date

May 15

Shares

27,535

Price

Value

View Form 4 on SEC.gov

Galvin Roy

EVP, Chief Commercial Officer

Other

Date

May 15

Shares

879

Price

$56.29

Value

$49K

View Form 4 on SEC.gov

Miller Laurie A.

SVP, Human Resources

Award

Date

May 15

Shares

13,323

Price

Value

View Form 4 on SEC.gov

Miller Laurie A.

SVP, Human Resources

Other

Date

May 15

Shares

948

Price

$56.29

Value

$53K

View Form 4 on SEC.gov

Simon, Christopher

President & CEO · Director

Award

Date

May 15

Shares

78,344

Price

Value

View Form 4 on SEC.gov

Simon, Christopher

President & CEO · Director

Other

Date

May 15

Shares

9,681

Price

$56.29

Value

$545K

View Form 4 on SEC.gov

DArecca James

EVP, Chief Financial Officer

Other

Date

May 1

Shares

655

Price

$59.26

Value

$39K

View Form 4 on SEC.gov

KROLL MARK W

Director

Purchase

Date

Nov 10

Shares

1,400

Price

$70.56

Value

$99K

View Form 4 on SEC.gov

Galvin Roy

EVP, Chief Commercial Officer

Other

Date

Oct 31

Shares

145

Price

$50.01

Value

$7K

View Form 4 on SEC.gov

Miller Laurie A.

SVP, Human Resources

Other

Date

Sep 17

Shares

238

Price

$49.95

Value

$12K

View Form 4 on SEC.gov

Zane Ellen M

Director

Award

Date

Jul 24

Shares

2,693

Price

Value

View Form 4 on SEC.gov

Pomeroy Claire

Director

Award

Date

Jul 24

Shares

2,693

Price

Value

View Form 4 on SEC.gov

KROLL MARK W

Director

Award

Date

Jul 24

Shares

2,693

Price

Value

View Form 4 on SEC.gov

Johnson Lloyd Emerson

Director

Award

Date

Jul 24

Shares

2,693

Price

Value

View Form 4 on SEC.gov

Dockendorff Charles J

Director

Award

Date

Jul 24

Shares

2,693

Price

Value

View Form 4 on SEC.gov

COYLE MICHAEL J

Director

Award

Date

Jul 24

Shares

2,693

Price

Value

View Form 4 on SEC.gov

Bryant Diane M

Director

Award

Date

Jul 24

Shares

2,693

Price

Value

View Form 4 on SEC.gov

⚡ = value ≥ $1M · Award/Option price shows — · formType=4 · securityName=Common Stock · url → sec.gov/Archives/edgar

1 / 4

Source: SEC EDGAR · Form 4 filings · ⚡ = value ≥ $1M · Award/Option price shows —

About HAE insider trading

HAE insider trades

Haemonetics Corporation (HAE) insider trading data is sourced from SEC Form 4 filings submitted by corporate insiders, including DArecca James (EVP, Chief Financial Officer), Galvin Roy (EVP, Chief Commercial Officer), Miller Laurie A. (SVP, Human Resources). Over the past 12 months, 5 insiders have filed transactions with the SEC. HAE insiders have been primarily buying, which may reflect pre-scheduled Rule 10b5-1 plan executions.

For Haemonetics Corporation's institutional ownership breakdown and insider ownership percentage, see the Ownership tab → Ownership tab →

Buy/Sell signal logic
acquisitionOrDisposition field:
A = Acquisition (buy) · D = Disposition (sell)
RSU vesting (M-Exempt) excluded from sentiment
Form 4SEC filing required within 2 business days of any insider transaction
10b5-1Pre-scheduled trading plan that allows insiders to sell on autopilot
Open MktDirect purchase or sale on the open market (excludes awards, options)

Frequently asked questions

HAE insider trading · 5 questions

The insiders of Haemonetics Corporation (HAE) include executives and directors such as DArecca James (EVP, Chief Financial Officer), Galvin Roy (EVP, Chief Commercial Officer), Miller Laurie A. (SVP, Human Resources), among others. Over the past 12 months, 5 insiders have filed Form 4 transactions with the SEC. Insider transactions are required to be reported within 2 business days of the trade date.

HAE board member insider tradingwho are HAE insidersHAE insider rosterHaemonetics Corporation executives insider activity

Source: FMP /stable/insider-trading/search · SEC EDGAR Form 3 & 4 · acquisitionOrDisposition A=Buy, D=Sell · RSU vesting (M-Exempt) excluded from sentiment bar · As of Jun 8, 2026